|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Provision for allowances, claims, and doubtful accounts | |||||
| Restructuring and other charges | |||||
| Impairment charges on assets | |||||
| Non-cash (gain) loss from derivatives | |||||
| Pension settlement charge (gain) | |||||
| Pension and other postretirement benefits curtailment gain | |||||
| Other items | |||||
| Change in operating assets and liabilities, net of effects of acquisitions: | |||||
| Receivables | |||||
| Inventories | |||||
| Other assets and liabilities | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Accrued taxes payable/receivable | |||||
| Deferred employee benefit costs | |||||
| Tenant improvement allowance | |||||
| Net adjustments | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Acquisitions, net of cash acquired | |||||
| Capital expenditures | |||||
| Proceeds from sale of property, plant, and equipment | |||||
| Proceeds from insurance settlement | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Repayment of debt | |||||
| Net proceeds of short-term borrowings | |||||
| Net proceeds from borrowings | |||||
| Payments made on borrowings | |||||
| Net decrease in book overdrafts | |||||
| Principal payments on finance lease obligations | |||||
| Dividends paid to stockholders | |||||
| Share repurchases | |||||
| Proceeds from exercise of common stock options | |||||
| Contingent payments related to acquisitions | |||||
| Proceeds from finance lease obligations | |||||
| Tax withholdings on stock-based compensation awards | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash—beginning of period | |||||
| Cash, cash equivalents, and restricted cash—end of period | |||||
| Cash paid during the period for: | |||||
| Interest paid to third parties, net | |||||
| Income taxes, net | |||||
| Noncash activities: | |||||
| Asset additions under operating leases | |||||
| Asset additions under finance leases | |||||
Loading...